Abnormal food timing and predisposition to weight gain: Role of barrier dysfunction and microbiota
- PMID: 33221482
- PMCID: PMC8016699
- DOI: 10.1016/j.trsl.2020.11.007
Abnormal food timing and predisposition to weight gain: Role of barrier dysfunction and microbiota
Abstract
Obesity has become a common rising health care problem, especially in "modern" societies. Obesity is considered a low-grade systemic inflammation, partly linked to leaky gut. Circadian rhythm disruption, a common habit in modern life, has been reported to cause gut barrier impairment. Abnormal time of eating, defined by eating close to or during rest time, is shown to cause circadian rhythm disruption. Here, using a non-obesogenic diet, we found that abnormal feeding time facilitated weight gain and induced metabolic dysregulation in mice. The effect of abnormal time of eating was associated with increased gut permeability, estimated by sucralose and/or lactulose ratio and disrupted intestinal barrier marker. Analysis of gut microbiota and their metabolites, as important regulators of barrier homeostasis, revealed that abnormal food timing reduced relative abundance of butyrate-producing bacteria, and the colonic butyrate level. Overall, our data supported that dysbiosis was characterized by increased intestinal permeability and decreased beneficial barrier butyrate-producing bacteria and/or metabolite to mechanistically link the time of eating to obesity. This data provides basis for noninvasive microbial-targeted interventions to improve intestinal barrier function as new opportunities for combating circadian rhythm disruption induced metabolic dysfunction.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis.Mol Metab. 2021 May;47:101183. doi: 10.1016/j.molmet.2021.101183. Epub 2021 Feb 4. Mol Metab. 2021. PMID: 33548500 Free PMC article.
-
Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.Cell Mol Gastroenterol Hepatol. 2020;9(2):219-237. doi: 10.1016/j.jcmgh.2019.10.011. Epub 2019 Nov 2. Cell Mol Gastroenterol Hepatol. 2020. PMID: 31689559 Free PMC article.
-
Metabolic Responses to Butyrate Supplementation in LF- and HF-Fed Mice Are Cohort-Dependent and Associated with Changes in Composition and Function of the Gut Microbiota.Nutrients. 2020 Nov 16;12(11):3524. doi: 10.3390/nu12113524. Nutrients. 2020. PMID: 33207675 Free PMC article.
-
Gut barrier disruption and chronic disease.Trends Endocrinol Metab. 2022 Apr;33(4):247-265. doi: 10.1016/j.tem.2022.01.002. Epub 2022 Feb 9. Trends Endocrinol Metab. 2022. PMID: 35151560 Review.
-
[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296. Orv Hetil. 2016. PMID: 26708682 Review. Hungarian.
Cited by
-
Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging.Microbiome. 2024 Feb 22;12(1):31. doi: 10.1186/s40168-024-01758-4. Microbiome. 2024. PMID: 38383483 Free PMC article.
-
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023 Mar 2;10:1120168. doi: 10.3389/fnut.2023.1120168. eCollection 2023. Front Nutr. 2023. PMID: 36937361 Free PMC article. Review.
-
Circadian disruption: from mouse models to molecular mechanisms and cancer therapeutic targets.Cancer Metastasis Rev. 2023 Mar;42(1):297-322. doi: 10.1007/s10555-022-10072-0. Epub 2022 Dec 14. Cancer Metastasis Rev. 2023. PMID: 36513953 Review.
-
Could "Eating Behavior" be a novel lifestyle factor that modulates risk of gastrointestinal cancers?Hepatobiliary Surg Nutr. 2022 Jun;11(3):430-432. doi: 10.21037/hbsn-22-17. Hepatobiliary Surg Nutr. 2022. PMID: 35693406 Free PMC article. No abstract available.
-
Inconsistent eating time is associated with obesity: A prospective study.EXCLI J. 2022 Jan 14;21:300-306. doi: 10.17179/excli2021-4324. eCollection 2022. EXCLI J. 2022. PMID: 35368461 Free PMC article.
References
-
- Must A, McKeown NM. The Disease Burden Associated with Overweight and Obesity. In Feingold KR, Anawalt B, Boyce A et al., eds. Endotext. South Dartmouth (MA) 2000.
-
- (WHO) WHO. Obesity and overweight. 2020. [cited; Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
-
- Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature 2017; 542: 177–85. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
